
WEHI Home Page
WEHI Biotech Centre
© Copyright 2006
Walter & Eliza Hall Institute
Contact the Webmaster
Local Time @ WEHI:
01:02PM on Saturday, May 17, 2008.
|
Collaborative Initiatives
Involving WEHI
Research Overview | Research
Divisions | Online Resources
| Collaborative Research
-
Bio21 draws together Victoria's leading
universities, research institutes, hospitals and industry to capitalise
on the State's world-class research and development capabilities.
The multi-million dollar Bio21 Institute and the Bio21 Proteomics
Facility are the first stage in a comprehensive program to
establish Bio21 Victoria as one of the world's leading biotechnology
centres
-
The
Joint ProteomicS Laboratory, a joint initiative of the Ludwig
Institute for Cancer Research and the Walter and Eliza Hall Institute
of Medical Research, continues to focus on analytical biochemistry,
technical developments in protein separation and characterisation,
and Proteomics.
-
The AGRF is a state-of-the-art facility for the
collection of molecular genetic information, covering large-scale
DNA sequencing, genotyping services and other resources for the genetic
and physical mapping of chromosomes, mutation detection and associated
bioinformatics.
-
Cancer Trials Australia is the leading provider of early phase cancer clinical trials because we aim for excellence in quality, timeliness and cost. We will achieve our vision by sustaining a collaborative culture, protecting our outstanding reputation, and actively encouraging innovation.
Cancer Trials Australia is a not-for-profit service organisation that operates with the highest standards of ethics and integrity. We build on the strengths of our staff by encouraging openness, communication, commitment, ideas, hard work and individual productivity.
-
The CRC-CGF was established in July 1991 to increase
the chance of success of Australian research into Cellular Growth
Factors, by integrating the unique and specialised skills of a
number of leading groups in this field of research.
Specialist skills in the CRC-CGF include in vitro
and in vivo biology, molecular biology, protein purification, protein
structure determination, molecular modelling, rational drug design
and, more recently, bioinformatics.
-
The Gene CRC was established in 1997 to enhance
the capacity of Australian academia, industry and society to apply
the wealth and diversity of genetic information that will accrue
over the coming decade and beyond.
-
Vaccines are one of the most cost-effective means
of protecting both humans and animals against disease. Drawing
on the expertise of world-class scientists, this Centre has been
formed to:
- Develop generic technologies for the design and development
of future vaccines;
- Assist industry in the application of these strategies to
specific medical and veterinary vaccines; and
- Train the scientists and technologists required to strengthen
Australia's vaccine industry.
The research program is organised in a matrix
structure involving generic disciplines and vaccine applications.
The generic program addresses both active immunisation (vaccination)
and passive immunotherapy, targeting preformed purified human antibodies
and other animicrobial substances, engineered antibodies and cellular
therapies. Applications include glandular fever, malaria, melanoma,
group A streptococcus and anaplasmosis. The CRC-VT was established
in July 1993.
-
The VBCRC is a consortium of medical research
institutes forming an institution without walls, and including
a number of Melbourne's leading research organizations.
-
The University of Melbourne Centre for Neuroscience
was constituted as an official centre of Melbourne University in
July 1999. It is intended that the Centre will have a role in promoting
a collaborative approach to neuroscience research involving campus-based
departments, associated institutes and teaching hospital departments
and institutes.
Back to the top...
Updated
11:27 AM (EST) on Tuesday, July 11, 2006.
|